Lina Davies Forsman
Lina Davies Forsman, MD, MGPH, PhD, adjunct lecturer
Senior Consultant Internal Medicine & Infectious Diseases
Affiliated researcher University of Sydney, Australia
~~I am a Senior Consultant in Infectious Disease and Internal Medicine at the Infectious Disease department of Karolinska University Hospital, Solna, Sweden. My main research interest is tuberculosis (TB), especially multidrug-resistant tuberculosis (MDR-TB), an interest set in motion by working for a year as a Senior Medical Officer in Tugela Ferry, Kwa-Zulu Natal, South Africa, Ten years after working in South Africa I successfully completed my thesis in Clinical Epidemiology, specialising in MDR-TB, at Karolinska Institutet, in 2018. I have been a member of the steering group of the Karolinska Institutet TB research centre and the National Advisory Board for TB in Sweden for several years. I also have an interest in other difficult to treat mycobacterial infections, including M.abscessus and MAC, and I am the chair of the Scandinavian NTM Expert Group.
I'm currently working in the University of Sydney, Australia, for an international postdoc with Professor Jan-Willem Alffenaar.
After my postdoc, I will return to Sweden as a research fellow, funded by Region Stockholm. My research group consists of three PhD students, for whom I am the main supervisor of two.
~~My research has focused on difficult to treat mycobacteria and treatment optimization, through repurposed and individualized therapy with therapeutic drug monitoring (TDM). In addition, I am interested in definitions of M.tuberculosis resistance and determination of the level of resistance, i.e. the minimum inhibitory concentration (MIC). Since my appointment as an adjunct lecturer at KI, I am also interested in evauating different pedagogical tools, such as team-based learning.
I am also interested in social determinants for tuberculosis and Global Public Health, sparked by my experiences from working with tuberculosis in a high-endemic country such as South Africa. I have several international collaborations, including Fudan University, Shanghai, China, the University of Sydney, Australia and Friends for International TB Relief, Vietnam. Currently, I coordinate a randomized controlled trial (RCT) in Sydney, Australia, investigating a new alternative for the treatment of pulmonary TB (NCT05664568) and initiating another RCT in Vietnam studying the feasibility of a shorter one month treatment of TB infection. I also lead microbiological, genomic, qualitative, prospective cohort studies and diagnostic accuracy studies.
Areas of interest:
Tuberculosis, multidrug-resistant tuberculosis, tuberculosis infection (latent TB)
Non-tuberculous mycobacterium Epidemiology Global Public Health Clinical trials Pharmacokinetics/pharmacodynamics Mycobacterial microbiology
Adjunct lecturer responsible for the Infectious Disease Course in the Medical Programme, Karolinska Institutet.
Main organiser of the national course "Tuberculosis" for residents in Infectious Diseases
Co-organiser of the Europe and Advanced Clinical Course of Tuberculosis (EACCTB) in Stockholm, 2017 and 2023
Postdoc University of Sydney, 2022-2023
Postdoc Region Stockholm, 2020-2022
Master of Global Public Health, 2020
Leading for change KI/KS, 2020-21
PhD Clinical Epidemiology, 2018
Research school for clinicians in Epidemiology, Karolinska Institutet, 2014-16
Consultant Infectious Disease, 2012
Consultant Internal Medicine, 2011
Registered Medical Practitioner, 2006
Academic honours, awards and prizes
2015 Pfizer scholarship 2014 Göran Sterner scholarship 2009 – 2022 Voted ”Best lecturer” 12 times by Karolinska medical students 2018 Nominated for the “Exemplary employee award”, Karolinska University Hospital (15 000 employees)